Angola plans to develop a pharmaceutical production complex by 2026, located in the ZEE of Icolo and Bengo. The facility aims to produce various medical products, including 1.7 million tablets and capsules, 50 million vials of injectable medicines, and other essential medical supplies. Currently in its early stages, the project is funded by the Angolan Sovereign Fund and is expected to be completed in 18 months, contributing to the local economy and healthcare improvement.
Angola is developing a pharmaceutical production complex expected to be operational by 2026. Located in the Special Economic Zone (ZEE) of Icolo and Bengo province, the facility aims to produce 1.7 million tablets and capsules annually along with 50 million vials of injectable medications.
Vitaflor company holds the responsibility for this initiative, which will also include the production of 35 million bags of serum and 13,000 kilograms of medical gases per day, as reported by Jornal de Angola.
The project is currently in its initial phase with the first construction stone laid, and stakeholders anticipate completion within the next 18 months. The Special Economic Zone currently hosts over 60 active business projects, primarily in the food and pharmaceutical sectors.
As stated by Manuel Pedro, the president of the board of directors of the SEZ, multiple industries will soon establish themselves in the area. This expansion will complement the existing 89 projects across diverse sectors already operational within the ZEE.
Angola’s initiative to establish a pharmaceutical production complex by 2026 marks a significant step in enhancing its healthcare capabilities. With high production targets for various medical substances and support from the Angolan Sovereign Fund, this project indicates progress in diversifying the economy and improving local health infrastructure. The project, spearheaded by Vitaflor, demonstrates the commitment to developing essential industries within the Special Economic Zone.
Original Source: www.plenglish.com
